Unknown

Dataset Information

0

Author Correction: Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity.

ABSTRACT:

SUBMITTER: Sant'Anna R 

PROVIDER: S-EPMC9898517 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity.
| S-EPMC4766415 | biostudies-literature
Unknown Development of a Highly Potent Transthyretin Amyloidogenesis Inhibitor: Design, Synthesis, and Evaluation.
| S-EPMC9661476 | biostudies-literature
Unknown AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin.
| S-EPMC3683741 | biostudies-literature
Unknown 3-O-Methyltolcapone and Its Lipophilic Analogues Are Potent Inhibitors of Transthyretin Amyloidogenesis with High Permeability and Low Toxicity.
| S-EPMC10779086 | biostudies-literature
Unknown Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
| S-EPMC5557047 | biostudies-literature
Unknown Cellular and Mitochondrial Toxicity of Tolcapone, Entacapone, and New Nitrocatechol Derivatives.
| S-EPMC11091965 | biostudies-literature
Unknown Author Correction: SGF29 nuclear condensates reinforce cellular aging.
| S-EPMC11830007 | biostudies-literature
Unknown A molecular mechanism for transthyretin amyloidogenesis.
| S-EPMC6390107 | biostudies-literature
Unknown Author Correction: Spontaneous shear flow in confined cellular nematics.
| S-EPMC6715445 | biostudies-literature
Unknown A substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity.
| S-EPMC2818972 | biostudies-literature